Pfizer director becomes OU's 20,000th MBA

Published: 9-Jul-2009

Dr Chris Martin, associate director of Strategic Alliances at Pfizer, is The Open University Business School\'s 20,000th MBA graduate.

Dr Chris Martin, associate director of Strategic Alliances at Pfizer, is The Open University Business School's 20,000th MBA graduate.

Martin combined full-time work with part-time study to earn the MBA. He began his career as a scientist with AstraZeneca, moving to Pfizer in 1999. He later found he enjoyed the project management and people side of his work more than the pure science and during a restructuring seized the opportunity to take up a business role. After initially completing a Postgraduate Certificate in Business Administration with the OU, he decided that its practice-based MBA would be a perfect fit with his lifestyle and new responsibility. "Throughout the three years of study I really challenged my way of thinking," he says. "The course gave me new ideas that I could feed into my daily work as well as developing me as a person and as a manager."

Martin's current role provides business support to the Pfizer's Research Units when working with external partners to create intellectual property.

Professor James Fleck, dean of The Open University Business School, said: "Chris's story highlights just one of the many thousands of successful MBA graduates who've studied our practice-based MBA."

You may also like